In plain English
Beam Therapeutics Inc. develops gene‑editing medicines to treat genetic diseases, focusing on rare disorders like glycogen storage disease…
Company stock · NASDAQ · USD
BEAM
Beam Therapeutics Inc
$24.05
Today
−$0.51-2.08%
vs yesterday’s close
Live price
- Opened at
- $24.00
- Day high
- $24.14
- Day low
- $23.24
- Yesterday’s close
- $24.56
- Sector
- Healthcare
- Industry
- Biotechnology
- Size
- Medium-sized company
- Market value
- $2.5 billion
- Number of shares
- 103.3 million
- Country
- US
- Went public
- Feb 6, 2020
- Exchange
- NASDAQ
- Website
- beamtx.com
Themes
Price chart Pro
Loading chart…
Loading chart…
Company briefing
What BEAM is
Plain English context — why the name shows up in the news, and what to watch next.
Latest on this name
Insights & deeper context
Cards about this company show up here when there is news.
No insights yet
Search another name, add BEAM to your watchlist, or check back when fresh news hits. If this company also trades in the US, the “Same company” link above opens that listing.
Back to feed →Company reports
Official filings (US SEC and linked cards)
No filings here yet
Official report cards for BEAM will show up here when available.
Broad market indexes (like the S&P 500, a basket of 500 large US companies) are shown through popular funds that track them (for example SPY). Company profile and prices use live market data when available.